Literature DB >> 2547846

Influence of cancer histology on the success of fine needle aspiration of the breast.

J Lamb1, T J Anderson.   

Abstract

Fine needle aspiration (FNA) cytology carried out on 1318 primary breast cancers from 1980 to 1986 inclusive showed that 198 were well recognised, histological special types. These included medullary, mucoid, tubular, cribriform and lobular invasive cancers, and non-invasive cancers. Excluding these special histological types, the overall number successfully identified (malignant plus suspicious) by fine needle aspiration was 940 (84%), although in only 820 (73%) was malignancy definitely diagnosed. The results for the special types were variable, the mucoid and medullary cancers being consistently identified while the other types were not. For tubular and cribriform, lobular and non-invasive ductal cancers a malignant diagnosis was made in 30% to 40% of cases, although inclusion of suspicious results gave identification figures of 60% to 70%. Particular cytological patterns are characteristic of some special histological cancer types but lesion cellularity, size, and physical definition are all intrinsic factors influencing success of FNA diagnosis. About 10% of all primary breast cancers seem to have certain histological properties which further reduce the success of fine needle aspiration.

Entities:  

Mesh:

Year:  1989        PMID: 2547846      PMCID: PMC1142024          DOI: 10.1136/jcp.42.7.733

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Fine needle aspiration cytology of "minimal" breast cancer.

Authors:  M Matsuda; S Nagumo; H Koyama; T Terasawa
Journal:  Acta Cytol       Date:  1986 Sep-Oct       Impact factor: 2.319

2.  Preoperative aspiration cytology of breast tumors.

Authors:  A J Eisenberg; S I Hajdu; J Wilhelmus; M R Melamed; D Kinne
Journal:  Acta Cytol       Date:  1986 Mar-Apr       Impact factor: 2.319

3.  Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project.

Authors:  T J Anderson; J Lamb; F Alexander; W Lutz; U Chetty; A P Forrest; A Kirkpatrick; B Muir; M M Roberts; A Huggins
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

4.  Role of fine needle aspiration cytology in breast cancer screening.

Authors:  J Lamb; T J Anderson; M J Dixon; P A Levack
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

5.  Fine-needle aspiration of breast cancer. Relationship of clinical factors to cytology results in 689 primary malignancies.

Authors:  G H Barrows; T J Anderson; J L Lamb; J M Dixon
Journal:  Cancer       Date:  1986-10-01       Impact factor: 6.860

6.  Fine needle aspiration cytology of breast masses: an evaluation of its accuracy and reasons for diagnostic failure.

Authors:  J J Patel; P C Gartell; J A Smallwood; A Herbert; G Royle; R Buchanan; I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1987-07       Impact factor: 1.891

7.  Fine needle aspiration cytology, in relationships to clinical examination and mammography in the diagnosis of a solid breast mass.

Authors:  J M Dixon; T J Anderson; J Lamb; S J Nixon; A P Forrest
Journal:  Br J Surg       Date:  1984-08       Impact factor: 6.939

8.  The Edinburgh randomised trial of screening for breast cancer: description of method.

Authors:  M M Roberts; F E Alexander; T J Anderson; A P Forrest; W Hepburn; A Huggins; A E Kirkpatrick; J Lamb; W Lutz; B B Muir
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

  8 in total
  4 in total

1.  Replace fine needle aspiration cytology with automated core biopsy in the triple assessment of breast cancer.

Authors:  D Clarke; N Sudhakaran; C A Gateley
Journal:  Ann R Coll Surg Engl       Date:  2001-03       Impact factor: 1.891

2.  Analysis of estrogen and progesterone receptors on preoperative fine-needle aspirates.

Authors:  B Frigo; S Pilotti; S Zurrida; L Ermellino; A Manzari; F Rilke
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

3.  Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry.

Authors:  I N Fernando; T J Powles; M Dowsett; S Ashley; L McRobert; J Titley; M G Ormerod; N Sacks; M C Nicolson; A Nash
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Can concurrent core biopsy and fine needle aspiration biopsy improve the false negative rate of sonographically detectable breast lesions?

Authors:  Yao-Lung Kuo; Tsai-Wang Chang
Journal:  BMC Cancer       Date:  2010-07-16       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.